共 261 条
[1]
Moore RG(2010)Current state of biomarker development for clinical application in epithelial ovarian cancer Gynecol Oncol 116 240-245
[2]
MacLaughlan S(1995)Is early detection of ovarian cancer possible? Ann Med 27 519-528
[3]
Bast RC(2009)HE4 as a biomarker for ovarian and endometrial cancer management Expert Rev Mol Diagn 9 555-566
[4]
Schwartz PE(1998)CA 125: the past and the future Int J Biol Markers 13 179-187
[5]
Taylor KJ(2007)Pre-operative prediction of serum CA125 level in women with ovarian masses J Med Assoc Thai 90 1986-1991
[6]
Li J(2014)Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients Br J Cancer 110 1517-1524
[7]
Dowdy S(2013)Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer Asian Pac J Cancer Prev 14 6241-6243
[8]
Tipton T(2013)Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts Arch Gynecol Obstet 288 859-865
[9]
Podratz K(2014)Combined detection of tumor makers in the diagnosis of ovarian tumors Int J Lab Med 35 724-725
[10]
Lu WG(1979)Fine needle aspiration cytology in gynecologic oncology. I. Clinical aspects Acta Cytol 23 277-281